Table 1.

Clinical characteristics of AIH patients and Healthy controls

Parameters	AIH	HC
NO	32	20
Age (years)	48 (37‐76)	51 (41‐74)
Gender: female/male	24/8	14/6
ALT (U/L)	125.9 ± 108.3*	27.2 ± 8.2
AST (U/L)	101.1 ± 53.7*	22.7 ± 5.7
γ‐GT (U/L)	89.1 ± 30.3*	25.1 ± 7.4
ALP (U/L)	133.4 ± 37.1*	89.5 ± 23.6
Bilirubin (umol/L)	12.5 ± 8.1*	10.8 ± 6.8
Albumin (g/L)	23.8 ± 5.7	25.3 ± 4.8
PT‐INR	1.0 ± 0.9	1.1 ± 0.6
Anti‐ANA (+)	23/32 (71.8%)*	0/20 (0%)
Anti‐ANA titre	1:640 (1:80‐1:10 000)	‐
Anti‐SMA (+)	2/32 (6.25%)	0/20 (0%)
Anti‐SMA titre	1:1000 (1:160‐1:3200)	‐
IgG (g/L)	15.9 ± 3.7*	7.8 ± 2.3
IgM (g/L)	6.9 ± 1.9*	2.64 ± 0.87
IgA (g/L)	4.07 ± 2.3*	1.6 ± 1.1
WBC (*10 9/L)	7.93 (5.6‐11.2)*	5.08 (3.9‐9.2)

Data shown are real case number or mean ± SD.

Normal values: ALP, alkaline phosphatase: 45‐125 μ/L; albumin: 35‐53 g/L; ANA, anti‐nuclear antibody: <1:80; SMA, anti‐mitochondrial antibodies: <1:80; HC, healthy control; AIH, autoimmune hepatitis; ALT, alanine aminotransferase: 5‐40 U/L; AST, aspartate transaminase: 5‐40 U/L; γ‐GT, gamma‐glutamyl transferase: 10‐60 μ/L; IgA:0.4‐2.3 g/L; bilirubin: 3.4‐20.5 umol/L; IgM: 0.7‐4.6 g/L; IgG: 7‐16 g/L.

^* P < .05 vs HC.